You could be right sean. One deal that could really move things along would be the bundling of HCV and HBV. If the AAV vector proves 100% successful, then this is a possibility. One thing is for sure, we are only a short time away from finding out what the market really thinks.
Efficacy and $, page-6
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)